Nabriva Therapeutics plc Long-Term Debt, Maturity, Year Five
Nabriva Therapeutics plc had Long-Term Debt, Maturity, Year Five of $11.89 million as of 2019-09-30, per its 10-Q filed 2019-11-12.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Four and Five
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive · last filed 2019-11-12
- 2019-09-30: Long-Term Debt, Maturity, Year Five $11.89M.
- 2019-06-30: Long-Term Debt, Maturity, Year Five $4.76M.
- 2019-03-31: Long-Term Debt, Maturity, Year Five $4.76M.
- 2018-12-31: Long-Term Debt, Maturity, Year Five $4.76M.
| Period end | Long-Term Debt, Maturity, Year Five |
|---|---|
| 2019-09-30 | $11.89M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $4.76M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $4.76M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $4.76M 10-K · filed 2019-03-12 |